New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 10, 2012
14:58 EDTSRPTMother urges for approval of Sarepta drug to help son, Rutland Herald reports
Jennifer NcNary, who has two sons with Duchenne muscular dystrophy, one in the clinical trial for eteplirsen and one not, has recently petitioned the FDA to give the Sarepta (SRPT) drug accelerated approval so that her other son can benefit from it. Reference Link
News For SRPT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for SRPT

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use